About Vascular Architects
Vascular Architects is a Healthcare company based in San Jose (United States) founded in 1999, and was acquired by LeMaitre Vascular in September 2007. Devices for peripheral vascular disease and nonvascular obstructions are developed. Vascular Architects has raised $42.6 million across 4 funding rounds from investors including Medtronic, Edwards Lifesciences and LeMaitre Vascular. The company was acqui-hired. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its competitors include Pulmonx, Spiration and Uptake Medical; 3 of its 3 listed competitors have raised funding.
Company details
Vascular Architects was founded in 1999 and is based in San Jose, United States. Medical devices are developed by the company for the treatment of peripheral vascular disease and nonvascular obstructions. A covered stent and controlled expansion delivery system have been created specifically for tracheobronchial strictures caused by malignant neoplasms or benign conditions. Operations focus on advancing these technologies within the vascular and interventional sectors.
- Headquarters San Jose, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vasculararchitects.com
- Acquired by LeMaitre Vascular (Sep 2007)
- Total Equity Funding$42.6M (USD)
in 4 rounds
- Latest Funding Round$6.6M (USD), Series E
Sep 2004
- InvestorsMedtronic
& 9 more
- Acquired byLeMaitre Vascular
(Sep 2007)
Funding Insights of Vascular Architects
Vascular Architects has successfully raised a total of $42.6M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $6.6 million completed in September 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.6M
- Total Rounds 4
- Last Round Series E — $6.6M
- First Round $20M
(May 2001)
- Investors Count 9
All 4 funding rounds of Vascular Architects with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2004 | $5M | Debt – Conventional | – | – | |
| Sep 2004 | $6.6M | Series E | – | Southern New Hampshire Health, Edwards Lifesciences | – |
| Jan 2003 | $16M | Series D | – | Southern New Hampshire Health | |
| May 2001 | $20M | Series C | – | Domain Associates, Medtronic | – |
10 investors in total: 10 institutional.
Investors in Vascular Architects
Vascular Architects has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Edwards Lifesciences and LeMaitre Vascular.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt is provided globally across multiple sectors. | 1980 | westerntech.com | Portola Valley, United States | |
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Investments in early and late-stage US companies are made. | vertical-group.com | Basking Ridge, United States | ||
Life science & tech focused VC firm investing in companies in the US | threearchpartners.com | San Mateo, United States | ||
| snhproviders.org | ||||
Medical devices for structural heart disease are developed and provided. | 1958 | edwards.com | Irvine, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
Devices for peripheral vascular disease treatment are developed and marketed. | 1983 | lemaitre.com | Burlington, United States |
Investor details for Vascular Architects
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vascular Architects
4 dated milestones of Vascular Architects across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Vascular Architects is founded.
- Funding First funding round of $20.0M.
- Funding Latest funding round, Series E, of $6.6M.
- Exit Acquired by LeMaitre Vascular.
Competitors of Vascular Architects
Vascular Architects has 3 listed competitors in our database, 3 of them funded. They include Pulmonx, Spiration and Uptake Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pulmonx.com | 1998 | Redwood, United States | $280.91M | 198 | Developer of smart devices for treating pulmonary diseases | |
| spiration.com | 1999 | Redmond, United States | $73.9M | 74 | IntraBronchial Valve to treat lung disease | |
| uptakemedical.com | 2005 | Tustin, United States | $71.68M | Targeted vapor therapy is developed for endoscopic lung volume reduction. |
Detailed competitors of Vascular Architects
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Vascular Architects (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vascular Architects
Complete news archive for Vascular Architects
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vascular Architects
Vascular Architects was founded in 1999 and raised its 1st funding round 2 years after it was founded.
Vascular Architects is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Vascular Architects is a funded company, having raised a total of $42.6M across 4 funding rounds to date. The company's 1st funding round was a Series C of $20M, raised on May 2001.
Vascular Architects was founded in 1999 and is based in San Jose, United States. Medical devices are developed by the company for the treatment of peripheral vascular disease and nonvascular obstructions. A covered stent and controlled expansion delivery system have been created specifically for tracheobronchial strictures caused by malignant neoplasms or benign conditions. Operations focus on advancing these technologies within the vascular and interventional sectors.
Vascular Architects's top competitors include Pulmonx, Spiration and Uptake Medical.
Vascular Architects has 10 investors. Key investors include Medtronic, Edwards Lifesciences, LeMaitre Vascular, Arch Venture Partners, and Western Technology Investment.
Yes. Vascular Architects was acquired by LeMaitre Vascular in September 2007.